|Articles|June 1, 2002
ISTA acquires rights to 3 ophthalmic compounds
Irvine, CA-ISTA Pharmaceuticals, Irvine, CA, entered into an agreement with AcSentient Inc. under which ISTA will acquire rights to three late-stage ophthalmology compounds.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants single-patient expanded access for urcosimod in neuropathic corneal pain
2
Q&A: What’s in the glaucoma treatment pipeline?
3
Sneak peek: What’s ahead at the second International Glaucoma Symposium in Mainz, Germany
4
What attendees can learn in a day: 2nd International Glaucoma Symposium
5























